In vitro effect of current antimalarial drugs on the survival of paired Schistosoma mansoni adult worms and their egg production.
10.2149/tmh.2010-04
- Author:
Yoshinori Mitsui
;
Yoshiki Aoki
- Publication Type:Journal Article
- Keywords:
antischistosomal drugs;
antimalarial drugs;
Schistosoma mansoni;
mefloquine;
quinine;
amodiaquine;
primaquine;
chloroquine;
pyrimethamine;
sulfadiazine
- From:Tropical Medicine and Health
2010;38(2):69-73
- CountryJapan
- Language:English
-
Abstract:
Some field trials have already demonstrated the high antischistosomal potential of combination therapies using Artesunate (ART) and current antimalarial drugs (Boulanger et al., 2007; Mohamed et al., 2009; Sissoko et al., 2009). The antischistosomal effects of these drugs are noteworthy, especially when they are used for the treatment of malaria in schistosomiasis endemic areas. However, the antischistosomal effects of Amodiaquine (AQ), Primaquine (PQ), Chloroquine (CQ) and Pyrimethamine (Py) have never been assessed by in vitro incubation. The objective of the present study is to assess the in vitro effects of current antimalarial drugs on the egg productivity of adult worm pairs of S. mansoni and their survival times. The effect of the current antimalarial drugs Mefloquine (MQ), quinine (QN), AQ, PQ, CQ, Sulfadiazine (Sf) and Py on the egg output of adult worm pairs of Schistosoma mansoni and their survival times during in vitro culture were assessed at a concentration of 10 Μg⁄ml. AQ, PQ, CQ and Py significantly inhibited the daily egg output of paired female worms at a concentration of 10 Μg⁄ml during the 1 or 2-day in vitro cultivation. However, QN and Sf did not significantly affect the daily egg output during the 8-day incubation. One-day exposure to MQ killed all paired male and female adult worms. AQ and PQ significantly decreased the survival of both paired male and female worms during the 14-day incubation, but QN, CQ, Py and Sf did not exert any similar effect. The present result is consistent with an assessment of the antischistosomal effects of artemisinin-based combination therapy in malaria and schistosomiasis co-endemic areas.
